NCT00524134 - P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions

Epilepsy

Interventions

DRUG

Carvedilol-CR

Week 1: 20mg capsule once daily Week 2-3: 40mg capsule once daily Week 4-15: 80mg once daily Week 16: tapering (40mg/day x 4d, then 20mg/day x 3d), unless the patient wishes to continue receiving the medication.

Trial Locations (1)

10032

Columbia Comprehensive Epilepsy Center, New York